Company Short-Term Debt: quidel.com (QDEL)

Public company logo of QuidelOrtho Corporation (QDEL)

QuidelOrtho leverages robust R&D capabilities in the development of molecular tests. Short-term loan capital on GURU.Markets reflects liability dynamics, where the value of 0.39 represents the latest figure. Long-term government contracts, which neutralize price competition, and a streamlined temperature-controlled delivery system for reagents to medical centers support the business's stability.

QDEL (QuidelOrtho Corporation) Company Short-Term Debts history from 07/04/2022 to 10/29/2026

Analytical breakdowns and data insights for company QuidelOrtho Inc. (QDEL)

- stock price and consensus target price:
Stock Price QuidelOrtho Corporation|QDEL - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Value QuidelOrtho Corporation|QDEL - Business Value
- shareholders' equity book value data:
Book Value per Share QuidelOrtho|QDEL - Book Capitalization|Market Value to Book Value Ratio quidel.com|QDEL - Aggregate Company Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio QuidelOrtho|QDEL - Long-Term Liabilities to Capital|Short-Term Debt to Equity QuidelOrtho|QDEL - Company Total Debt Obligations|Debts to Book Capitalization QuidelOrtho Corporation|QDEL - Long-Term Debt Volume|Company Short-Term Debt QuidelOrtho
Fundamental company analysis:QuidelOrtho Corporation (QDEL)
Flagship merchandise of QuidelOrtho

High barriers to entry in the laboratory diagnostics sector provide QuidelOrtho (QDEL) with stable cash flows, enabling the efficient management of obligations maturing within one year. Analyzing the current debt ratio helps assess liquidity risk and the effectiveness of financial leverage, where a downward trend indicates increasing financial stability for the business in the face of market volatility.

Competitors of QuidelOrtho

Agilent - Company Short-Term Debts|DGX - Company Short-Term Debts|Illumina Corp (ILMN) - Company Short-Term Debt|Company Short-Term Indebtedness EXAS|RVTY (Revvity, Inc.) - Company Short-Term Debts|Company Short-Term Debts bio-rad.com|Company Short-Term Debt Anbio (NNNN)|Company Short-Term Debt SHC (Sotera Health Corp)|OPKO Corp - Company Current Liabilities|CareDx (CDNA) - Short-Term Debt|MRVI - Company Short-Term Debt|Short-Term Debt Volume fulgentgenetics.com FLGT|LAB: Company Short-Term Debts|CTKB - Short-Term Debt Volume|Company Short-Term Debt OraSure Technologies Inc|Exagen Diagnostics (XGN) - Short-Term Debt Volume|Company Short-Term Debt MDxHealth SA (MDXH)|luciddx.com (LUCD) - Short-Term Indebtedness|Prenetics - Company Current Liabilities|Company Short-Term Debts Insight Molecular Diagnostics, Inc. IMDX|Trinity Biotech Corp - Company Short-Term Debts|Short-Term Debt Volume ProPhase Labs Corp PRPH|AIMD: Company Short-Term Debts|Company Short-Term Indebtedness CODX|HSCS (HeartSciences) - Company Short-Term Debts|Short-Term Debt Biomerica Inc. BMRA|Company Short-Term Debt Cardio Diagnostics (CDIO)|Company Short-Term Debt VRAX (Virax Biolabs Corp)|Company Short-Term Debt Bluejay Diagnostics BJDX|aspirawh.com (AWH) - Short-Term Debt|AXDX - Company Short-Term Debt|Company Short-Term Loans and Borrowings CNTG (CENTOGENE N.V.)|ENZ (enzo.com) - Company Current Liabilities|FRES: Amount of Current Liabilities|GENE (Genetic Technologies Ltd) - Company Short-Term Debts|ME: Company Short-Term Loans and Borrowings|Company Short-Term Debt Psychemedics Corporation (PMD)